Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Rare Diseases 2Connective Tissue Diseases 2Arthritis 2

Interventions

Microbial Collagenase 15xiapex 10Collagenases 4Surgical Procedures, Operative 2Sodium Chloride 2Triamcinolone Acetonide 1Transplantation 1Tranexamic Acid 1Therapeutics 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy 1Oxycodone 1Ibuprofen 1High-Energy Shock Waves 1Extracorporeal Shockwave Therapy 1Enzymes 1Dexamethasone 1Adrenal Cortex Hormones 1Adalimumab 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Dupuytren Contracture × Collagenases × Clear all
NCT02725528 2023-07-18

EXTEND

McMaster University

Phase 3 Completed
22 enrolled 15 charts

Dupuytren Contracture

NCT01450397 2017-04-17

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Hospital for Special Surgery, New York

Phase 4 Completed
5 enrolled 5 charts

Dupuytren Contracture

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 2 Completed
36 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

NCT00014742 2015-03-25

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 3 Completed
72 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡